Observational studyClinical genitourinary cancer2017

Impact of Sequencing Targeted Therapies With High-dose Interleukin-2 Immunotherapy: An Analysis of Outcome and Survival of Patients With Metastatic Renal Cell Carcinoma From an On-going Observational IL-2 Clinical Trial: PROCLAIM

Joseph I Clark et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.